Manifestation and epidemiology of contagious bovine pleuropneumonia in Africa

被引:49
作者
Masiga, WN
Domenech, J
Windsor, RS
机构
[1] CIRAD,EMVT,DEPT ELEVAGE & MED VET,CTR COOPERAT INT RECH AGRON DEV,F-34032 MONTPELLIER,FRANCE
[2] SCOTTISH AGR COLL,VET SERV,DUMFRIES DG1 1DX,SCOTLAND
来源
REVUE SCIENTIFIQUE ET TECHNIQUE DE L OFFICE INTERNATIONAL DES EPIZOOTIES | 1996年 / 15卷 / 04期
关键词
Africa; bovines; contagious bovine pleuropneumonia; disease control; distribution; epidemiology; lesions; Mycoplasma mycoides subsp. mycoides SC; symptoms;
D O I
10.20506/rst.15.4.980
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Contagious bovine pleuropneumonia (CBPP) is one of the major threats to cattle health and production in Africa. This article reviews the clinical manifestations, lesions and epidemiology of the disease. The clinical manifestations and lesions are typical and are no different in Africa from those seen in other countries. CBPP is a respiratory disease characterised by pneumonia and serofibrinous pleurisy. The usual form of this disease is acute but chronic forms are frequent, particularly in endemic regions. Hyperacute forms, with a high mortality rate, can be seen at the beginning of outbreaks in newly infected regions. The epidemiology of the disease in Africa is dominated by four factors, namely: cattle are the only species affected, there is no reservoir in wild animals, clinical cases or chronic carriers are the usual sources of infection, through direct contact, and cattle movements play a very important role in the maintenance and extension of the disease. CBPP is widespread in Africa and according to the Office International des Epizooties and to various reports in 1995, the disease is present in 24 countries of tropical Africa. In western Africa, CBPP is mainly enzootic or sporadic but in some countries the incidence is increasing. The situation in Central Africa is not very alarming. However in eastern and south-eastern Africa, CBPP has become a major issue, placing southern Africa under direct threat. An evaluation of economic losses due to the disease and the cost-benefit ratio of control programmes is indispensable, since such economic assessments are needed before policy-makers decide on programmes of control or eradication. This is an area which needs to be addressed immediately as the launching of new campaigns, particularly in eastern and soothern Africa, is urgently needed.
引用
收藏
页码:1283 / 1308
页数:26
相关论文
共 51 条
[1]  
BLOOD DC, 1980, VET MED
[2]   ISOLATION AND IDENTIFICATION OF MYCOPLASMA-MYCOIDES SUBSPECIES MYCOIDES SC STRAINS IN SHEEP AND GOATS [J].
BRANDAO, E .
VETERINARY RECORD, 1995, 136 (04) :98-99
[3]  
CHARDONNET P, 1995, PERIPNEUMONIE CONTAG
[4]  
*CTR COOP INT RECH, 1992, 4 CIRADEMVT CTR COOP
[5]  
*DIR NAT EL, 1992, PROJ PARC GUIN RAPP
[6]  
*DIR NAT EL, 1996, RAPP ANN ACT 1995 RA
[7]  
DITUTALA LS, 1995, P AN DIS RES I ADRI
[8]  
DOMENECH J, 1996, P PAN RIND CAMP PARC
[9]  
DOMENECH J, 1988, THESIS CRETEIL U PAR
[10]  
DUFOUR B, 1994, OUTILS AIDE DECISION, V3